In the present study, the administration of nicotinamide/streptozotocin resulted in an insulin resistance and an increase in the rate of IL-1β and TNF-α, confirming their involvement in the pathogenesis of type II diabetes. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.